Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000276919 is annotated as a region of non-coding RNA, specifically Maternally expressed 3 conserved region 2 (MEG3_2), identified in Ensembl and RFAM databases[3]. It does not encode a protein product and is cataloged as "misc RNA." No well-defined function, disease association, or relevance as a therapeutic target has been established for this transcript. This RNA may be part of a cluster of non-coding RNAs at the MEG3 locus, but the specific role, structure, or involvement in pathobiology is not currently described in publicly available sources. ENSG00000276919 (MEG3_2) is a non-coding RNA with no established relevance as a drug target, no known functions, and no documented interactions or disease associations in the current scientific literature[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Maternally expressed 3 conserved region 2 (MEG3_2).